In this study, we show evidence of this mechanism of action with differentiation of leukaemia cells, persistence of cytogenetic abnormalities at the time of morphologic response and differentiation syndrome associated with menin inhibition in some patients, which resolved following appropriate therapy. The gene discussed is MEN1; the disease is leukemia.